Malignant Hemopathies
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology (NCT02140736) | Hospira, now a wholly owned subsidiary of Pfizer | 2009-09-01 |
Track Malignant Hemopathies automatically
Every clearance here is in the API, with alerts when new ones post.